Cargando…
Real-life experience with 4 years of golimumab persistence in ulcerative colitis patients
Golimumab has demonstrated its long-term efficacy and safety in ulcerative colitis in clinical trials, but no data of long-term persistence has been published from real world. To estimate long-term persistence of golimumab, as well as factors associated with longer persistence, in patients with ulce...
Autores principales: | Iborra, Marisa, García-Morales, Natalia, Rubio, Saoia, Bertoletti, Federico, Calvo, Marta, Taxonera, Carlos, Boscá-Watts, Marta Maia, Sierra, Mónica, Mancenido, Noemí, Beltrán, Belén, Nantes Castillejo, Óscar, García-Planella, Esther, Vera, Isabel, Alba, Cristina, Martí-Aguado, David, Ballester, María Pilar, Cano-Sanz, Noelia, Pajares-Villarroya, Ramón, Cerrillo, Elena, Cañada, Antonio, Nos, Pilar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576126/ https://www.ncbi.nlm.nih.gov/pubmed/33082359 http://dx.doi.org/10.1038/s41598-020-73577-0 |
Ejemplares similares
-
Possible Biomarkers in Blood for Crohn's Disease: Oxidative Stress and MicroRNAs—Current Evidences and Further Aspects to Unravel
por: Moret-Tatay, Inés, et al.
Publicado: (2016) -
Short-term effectiveness of golimumab for ulcerative colitis: Observational multicenter study
por: Bosca-Watts, Marta Maia, et al.
Publicado: (2016) -
Identification of Epigenetic Methylation Signatures With Clinical Value in Crohn's Disease
por: Moret-Tatay, Inés, et al.
Publicado: (2019) -
Specific Plasma MicroRNA Signatures in Predicting and Confirming Crohn's Disease Recurrence: Role and Pathogenic Implications
por: Moret-Tatay, Inés, et al.
Publicado: (2021) -
Influence of Vitamin D Deficiency on Inflammatory Markers and Clinical Disease Activity in IBD Patients
por: López-Muñoz, Pedro, et al.
Publicado: (2019)